The estimated net worth of Geoffrey Lynn is at least $1.56M dollars as of 31 Dec 2024. Geoffrey Lynn is the Chief Scientific Officer of Barinthus Biotherapeutics plc. and owns shares of Barinthus Biotherapeutics plc. (BRNS) stock worth about $1.56M.
There are no insider transactions reported by Geoffrey Lynn
We use cookies and similar technologies to provide certain features, enhance
the user experience and deliver content that is relevant to your interests.
Depending on their purpose, analysis and marketing cookies may be used in
addition to technically necessary cookies. By clicking on "Agree and
continue", you declare your consent to the use of the aforementioned cookies.
Here
you can make detailed settings or revoke your consent (in part if necessary)
with effect for the future. For further information, please refer to our
Privacy Policy
.